Born in Murska Sobota, Slovenia, Dr. Vladimir Kepe received his BS in chemistry in 1990 and his PhD (Chemistry) in 1996 from University of Ljubljana, Ljubljana, Slovenia. He moved to Los Angeles in 1997 to the Barrio lab at UCLA as a post-doctoral fellow. Since then he has worked on a multitude of projects in organic synthetic chemistry, radiosynthesis, determination of biodistribution and dosimetry for new PET tracers, microPET imaging experiments, human PET imaging experiments and PET imaging data analysis. Since 2003 his focus has been on in vivo imaging of pathological brain protein aggregates with [F-18]FDDNP PET in sporadic and familial Alzheimer's disease, prion diseases, Down's syndrome, Parkinson's disease, and Huntington's disease. His more recent interests include PET imaging of neuroreceptors (serotonin 1A), sodium dependent glucose transporters (SGLTs) and estrogen sulfortransferase in neurodegenerative disorders and related conditions.